From NBC News:
The White House said Friday it’s adding three drugs for diabetes and lung disease to the self-pay platform TrumpRx, as the administration works to expand the site as part of its push to lower drug prices.
The drugs, from German drugmaker Boehringer Ingelheim, are Jentadueto and Jentadueto XR, for Type 2 diabetes, as well as the COPD drug Striverdi Respimat.
According to the White House, the diabetes drugs list for about $525 but are priced on TrumpRx starting around $55, while the COPD drug is listed at about $35, down from roughly $276.
The White House’s healthcare cost reduction platform, launched in January, but it has faced criticism for its limited scope and discounts that can’t be used with insurance.
Awareness about TrumpRx among consumers is low, with only a third of prescription drug users saying they are familiar with it and only 7% of those saying they visited the site to compare prices, according to a survey published last week by KFF.
The White House has not reported on the number of visits to the site since it launched.
Read more at NBC News
The Dennis Michael Lynch Podcast archive is available below, with the most recent on top. Never miss an episode. Subscribe to the show by downloading The DML News App or go to Apple Podcasts.
